SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizers sustained rally to a 52-week high and push through a long-watched round-number level are driving attention, with holders celebrating the recovery while skeptics question whether it can hold without a stronger company-specific catalyst. Traders are also watching the upcoming earnings report and pipeline developments for confirmation.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Traders are focused on reports that Trump ruled out an immediate U.S. strike on Iran, with many interpreting the news as a possible relief-driven futures bounce while others argue conflict and oil-supply risks are merely delayed. The debate is amplifying an already cautious, volatile outlook ahead of the Fed decision, major tech earnings and inflation data.

Centrus Energy Corp. engages in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment includes various components of nuclear fuel to utilities from its global network of suppliers. The Technical Solutions segment offers advanced engineering, design, and manufacturing services to government and private sector customers, and is deploying advanced nuclear fuel production capabilities to power existing, and next-generation reactors around the world. The company was founded in October 1992 and is headquartered in Bethesda, MD.

Centrus Energy Corp - Ordinary Shares - Class A

Centrus Energy Corp 

Centrus stock-and-warrant offering has intensified concern about shareholder dilution and contributed to a steep selloff, alongside broader weakness in nuclear stocks. Traders are divided between viewing the pullback as a buying opportunity tied to domestic uranium-enrichment demand and worrying that valuation, expansion costs, and execution risks outweigh the long-term HALEU and DOE-contract potential.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

FDA clearance to expand Alpha Taus recurrent glioblastoma REGAIN trial and anticipated follow-up data are driving attention, alongside progress in its pancreatic cancer program. Traders are optimistic about the early GBM signal but acknowledge that it comes from a small cohort and await larger-data validation.

Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC. The Americas segment consists of the United States of America, Canada, Mexico, and South America. The EMEA segment includes Europe, Middle East, and Africa. The APAC segment focuses on Japan, China, South Korea, India, Singapore, Malaysia, and Australia. The company was founded by William Marine Banyai, Emily Marine Leproust, and Bill James Peck in 2013 and is headquartered in San Francisco, CA.

Twist Bioscience Corp

Discussion is focused on the $17.05 million investor settlement: eligible shareholders are being reminded to file claims before the deadline, with a final approval hearing scheduled immediately afterward. Some traders view clearing the legal overhang as a positive, while others emphasize the settlements limited per-share recovery and historical allegations about Twists production and financial disclosures.

VanEck ETF Trust - VanEck Gold Miners ETF

VanEck Gold Miners ETF

Golds pullback and concern that hotter inflation could keep interest rates higher are weighing on gold-miner shares, which can magnify moves in bullion. Traders are divided between buying the decline and expecting more downside, while watching for signs that gold and miners can stabilize.

ProShares Trust II - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

Volatile natural-gas futures are driving discussion, with traders weighing winter-weather demand and storage reports against mild-weather forecasts, strong production, and ample supply; pipeline and Freeport disruptions have also sparked sharp moves. Views are split on whether gas can sustain a rebound, while many warn that BOILs leveraged futures exposure and decay make it especially risky to hold.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is drawing attention as crude rallies on fears that escalating Iran and broader Middle East tensions could disrupt oil supplies and shipping. Bulls see tight supply and continued geopolitical risk supporting the move, while bears argue the rally may be overextended and could reverse if tensions ease or a deal emerges.

ProShares Trust - ProShares UltraPro Short QQQ -3x Shares

ProShares UltraPro Short QQQ

Traders are focused on SQQQ as a leveraged hedge against the Nasdaq, citing tech weakness and concerns that heavy AI spending may not deliver adequate returns, alongside interest-rate and geopolitical risks. Some expect further downside in tech and favor SQQQ, while others caution that its daily leverage can erode value and that a Nasdaq rebound could reverse its gains.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Amgens Phase 3 lung-cancer results for IMDELLTRA plus Imfinzi are drawing attention, with traders focused on the reported survival benefit and potential to expand the drugs role in earlier treatment. The community views the data as a meaningful pipeline catalyst, though some question how much it will change Amgens broader growth outlook.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

UBER Stock In Focus: Uber's $2.3B Bet On ezCater Fails To Lift Retail Mood 

Equity

Uber’s $2.3 billion ezCater deal has drawn retail investor criticism, with traders questioning the acquisition’s value.


UBER Stock Rises Overnight: Rosenblatt Calls Uber A 'Durably Compounding Platform', Sees 32% Upside 

Rosenblatt sees Uber as having strong long-term growth potential as AI becomes more widely used in software development. 


Intel-Backed Mobileye Faces Fresh Analyst Skepticism Over Robotaxi Ambitions – But Retail Remains Bullish

Jefferies initiated coverage with an “Underperform” rating and set a $8 price target. 


Tesla’s Autonomous Driving Rival Mobileye Secures Deal With Major US Automaker — MBLY Stock Gains

Mobileye stated that it will integrate its Driver Monitoring System into future vehicles equipped with the EyeQ6L system-on-chip.

Uber To Add Zoox Robotaxis To Its Ride-Hailing Fleet: Retail Says The Deal 'Makes The Most Sense For Amazon'

The integrated fleet rollout is set to begin in Las Vegas in summer 2026, with Los Angeles scheduled to follow by 2027.


Uber Slumps Over 5% on Tepid Outlook: ETFs in Focus 

Uber beats revenue estimates in Q4, but softer profit guidance pressures shares. Delivery growth remains strong. 

Roundhill ETF Trust - Roundhill Robotaxi, Autonomous Vehicles & Technology ETF

Neutral Sentiment

<ul class="summary-bullets"><li>Uber’s ezCater deal will combine Uber Eats’ network with ezCater’s corporate catering platform.</li><li>ezCater generated over $2.5 billion in bookings, with average orders exceeding $400.&nbsp;</li><li>Retail investors worry Uber’s aggressive acquisitions could distract from buybacks and autonomous vehicle growth.&nbsp;</li></ul>Uber Technologies Inc. (UBER)’s $2.3 billion ezCater acquisition has failed to evoke retail traders’ enthusiasm. The deal expands Uber’s reach into lucrative group and workplace catering, but the hefty price tag and retail reaction suggest investors want more than another growth bet.&nbsp;<a href="https://stocktwits.com/symbol/UBER">Uber Technologies stock</a> inched 0.06% higher overnight, ahead of Wednesday.&nbsp;&nbsp;<h2 class="st-heading-2">Acquisition Expands Uber’s&nbsp;Catering Reach</h2>Uber and ezCater have agreed to an all-cash transaction that combines Uber Eats’ restaurant and consumer network with ezCater’s catering platform. The deal will give businesses a simpler way to arrange meals for meetings, events, recurring workplace needs and other group occasions.ezCater connects businesses with more than 140,000 restaurants across the U.S. Its platform also provides tools for managing food budgets and orders. Uber expects the deal to help restaurants secure larger orders and attract customers who may later become individual diners.“Catering is a big business, and can be a huge revenue stream for restaurants,” said Dara Khosrowshahi, CEO, Uber.ezCater recorded more than $2.5 billion in gross bookings during the latest 12-month period, representing growth in the high-teens percentage range from a year earlier. ezCater’s typical order exceeds $400, highlighting the appeal of the catering business compared with smaller individual food orders.<h2 class="st-heading-2">Uber’s Mega-Deal Strategy Worries Retail Investors&nbsp;&nbsp;</h2>Retail investors have not been happy with Uber’s 2026 dealmaking strategy, mainly because the company is spending heavily and taking on more financial risk. Its proposed €13 billion ($14.8 billion) cash deal for Delivery Hero, supported by a €14 billion bridge loan, raised concerns about higher debt and the challenges of combining businesses across many international markets.Rather than directing the record $10 billion free cash flow toward share buybacks or autonomous vehicle (AV) fleet partnerships, Uber's appetite for mega-deals has expanded with&nbsp; ezCater. Everyday investors fear this return to debt-fueled growth will dilute near-term earnings, threaten capital returns, and distract management from core AV competition threats.&nbsp;<h2 class="st-heading-2">What Did UBER Retail Traders Say&nbsp;</h2>On Stocktwits, retail sentiment around the stock remained in ‘bearish’ territory.&nbsp;A user&nbsp;<a href="https://stocktwits.com/Kabooki/message/665920916">said</a>, “Uber management needs to be replaced. They keep buying garbage companies. They need to concentrate on core business. No one owns cars anymore in major cities. Massive money to be made. Stop the stupid m&amp;a.”Another user&nbsp;<a href="https://stocktwits.com/boolfool/message/665881075">said</a>, “Unreal. Why are you buying a catering company and not executing buybacks?”A third user&nbsp;<a href="https://stocktwits.com/Smart_Money22/message/665891317">said</a>, “Gonna sell this, man. I can’t believe it, dead money for at least a year more. Tax harvest time.”&nbsp;UBER stock has declined over 15% year-to-date.&nbsp;Also see:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nvidia-backed-cloud-computing-firm-lambda-looks-to-raise-4-b-in-final-round-ahead-of-ipo-report/cZDtgW7RBli">Nvidia-Backed Cloud Computing Firm Lambda Looks To Raise $4B In Final Round Ahead Of IPO: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Uber logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Uber Technologies Inc. (UBER)’s $2.3 billion ezCater acquisition has failed to evoke retail traders’ enthusiasm. The deal expands Uber’s reach into lucrative group and workplace catering, but the hefty price tag and retail reaction suggest investors want 

UBER Stock In Focus: Uber's $2.3B Bet On ezCater Fails To Lift Retail Mood

BlackRock Institutional Trust Company N.A. - iShares U.S. Transportation ETF

Uber Technologies Inc

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Fundamentals

Info

CABZ Roundhill ETF Trust - Roundhill Robotaxi, Autonomous Vehicles & Technology ETF

Fundamentals

Latest CABZ News